info icon

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

C3_BONE_CARTILAGE_LIMBS_WIDE

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 C40
  • Hospital discharge: ICD-9 170[4-5]|170[7-8]
  • Hospital discharge: ICD-8 170[4-5]|170[7-8]
  • Cause of death: ICD-10 C40
  • Cause of death: ICD-9 170[4-5]|170[7-8]
  • Cause of death: ICD-8 170[4-5]|170[7-8]
  • Cancer registry: Topography ICD-O-3 C40
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

3 out of 7 registries used, show all original rules.

366

4. Check minimum number of events

None

366

5. Include endpoints

None

366

6. Filter based on genotype QC (FinnGen only)

352

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 352 165 187
Unadjusted period prevalence (%) 0.07 0.06 0.09
Median age at first event (years) 51.87 51.62 52.08

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
366
Matched controls
3660
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
144.9
207.3
104
10
H02AB02
ATC
dexamethasone; systemic
81.2
133.7
72
11
130
Kela drug reimbursment
Malignant tumour
+∞
124.2
112
*
A04AA01
ATC
ondansetron; systemic, rectal
20.3
74.6
60
35
NF3AA
NOMESCO Finland
Femur X-ray examination
17.7
69.8
60
40
N02AA05
ATC
oxycodone; systemic
7.3
65.9
123
237
JN4BD
NOMESCO Finland
Extensive body CT
12.2
64.9
71
71
A03FA01
ATC
metoclopramide; systemic, rectal
7.1
63.1
121
239
C40.21
ICD-10 Finland
Osteosarcoma of the long bones of the lower extremity
+∞
57.9
54
*
C40.20
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity without histology
+∞
56.8
53
*
9180/3-C40.2
ICD-O-3
Osteosarcoma, NOS, of long bones of lower limb and associated joints
+∞
55.7
52
*
JN4AD
NOMESCO Finland
Body CT examination
10.5
54.0
65
74
C40.22
ICD-10 Finland
Chondrosarcoma of the long bones of the lower extremity
+∞
53.5
50
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
19.1
50.4
41
24
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
10.9
50.3
58
62
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
22.8
49.3
37
18
C40.29
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity other or unspecified histology
+∞
49.1
46
*
C40.2
ICD-10 Finland
Malignant neoplasm: Long bones of lower limb
+∞
46.9
44
*
Z51.5
ICD-10 Finland
Palliative care
12.4
46.0
48
44
L03AA02
ATC
filgrastim; parenteral
495.0
45.3
44
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
482.2
44.2
43
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
+∞
43.6
41
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
40.4
38
*
A04AA02
ATC
granisetron; systemic, transdermal
431.5
39.9
39
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.7
39.7
54
71
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
38.2
36
*
NG4AA
NOMESCO Finland
Lower leg X-ray examination
10.0
38.0
46
52
GD1AD
NOMESCO Finland
Thorax CT examination
8.7
37.5
51
67
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
199.0
35.4
36
*
C40.00
ICD-10 Finland
Malignant tumor of the scapula and the long bones of the upper extremity without histology
+∞
35.0
33
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
33.9
32
*
ZXE20
NOMESCO Finland
More than three and less than five hours
4.9
32.7
86
217
WW500
NOMESCO Finland
Blood transfusion
12.0
31.5
33
30
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
4.6
31.2
88
234
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
12.9
31.1
31
26
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.4
31.0
48
73
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
30.7
29
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.2
30.4
57
106
L03AA13
ATC
pegfilgrastim; parenteral
116.5
30.2
32
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
8.2
29.9
42
57
115
Kela drug reimbursment
Breast cancer
+∞
29.6
28
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
28.5
210
1050
B01AB05
ATC
enoxaparin; parenteral
3.4
28.4
151
620
B01AB10
ATC
tinzaparin; parenteral
5.7
28.3
58
117
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
157.0
28.1
29
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
27.4
26
*
9220/3-C40.2
ICD-O-3
Chondrosarcoma, NOS, of long bones of lower limb and associated joints
+∞
27.4
26
*
WX402
NOMESCO Finland
General anaesthesia
3.9
27.1
99
317
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
26.4
25
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
26.1
123
465
R4110
NOMESCO Finland
Physiotherapy
3.3
25.7
137
558
C40.90
ICD-10 Finland
Malignant tumor in unspecified locations in the bones of the extremities and articular cartilage without histology
+∞
25.3
24
*
PJA12
NOMESCO Finland
Sentinel node biopsy
267.5
25.0
25
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
24.2
23
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
24.2
23
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
24.2
23
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
33.7
24.1
31
10
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
7.7
23.3
34
48
17071
ICD-8 Finland
Malignant neoplasm of bone, Lower limb, long bones
+∞
23.2
22
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.1
22.9
146
653
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
25.9
22.6
31
13
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.7
22.6
45
88
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
22.1
21
*
C40.02
ICD-10 Finland
Chondrosarcoma of the scapula and long bones of the upper extremity
+∞
22.1
21
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
41.4
22.0
27
7
N03AX14
ATC
levetiracetam; systemic
9.6
21.4
26
29
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
+∞
21.0
20
*
NGB30
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part - connected prosthesis
81.7
20.9
23
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.3
20.9
26
30
NB6AA
NOMESCO Finland
Humerus X-ray examination
8.8
20.8
27
33
WF002
NOMESCO Finland
Radical radiotherapy
61.1
20.1
23
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.5
20.0
41
82
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
20.0
19
*
C40.99
ICD-10 Finland
Malignant tumor in unspecified locations in the bones of the extremities and articular cartilage other or unspecified histology
+∞
20.0
19
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
19.8
88
315
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.0
18.9
60
171
9101
FHL
Bone biopsy
+∞
18.9
18
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
199.8
18.7
19
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
18.4
154
778
NG1DG
NOMESCO Finland
Knee and lower leg very extensive MRI examination with high intensity magnet
70.2
17.9
20
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
17.9
17
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
100.0
17.7
19
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
15.8
17.4
28
19
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
37.0
16.9
21
6
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
16.8
16
*
C40.01
ICD-10 Finland
Osteosarcoma of the scapula and the long bones of the upper extremity
+∞
16.8
16
*
C40.91
ICD-10 Finland
Osteosarcoma in unspecified locations in the bones and articular cartilage of the extremities
+∞
16.8
16
*
C40.10
ICD-10 Finland
Malignant tumor of the upper limb's short bones without histology
+∞
16.8
16
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
16.8
16
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
16.8
16
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
16.8
134
656
C61
ICD-10 Finland
Malignant neoplasm of prostate
177.8
16.6
17
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.7
16.3
58
179
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
16.1
87
346
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.0
16.0
49
136
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
15.7
15
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
166.8
15.6
16
*
ZXA05
NOMESCO Finland
Left side
2.6
15.6
116
546
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.6
15.4
30
57
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
6.6
15.2
25
40
JN4CD
NOMESCO Finland
Very extensive body CT
15.9
15.1
24
16
N03AX16
ATC
[U] pregabalin
2.7
14.8
102
460
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
14.7
14
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
14.7
14
*
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
156.0
14.6
15
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
12.7
14.3
25
21
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
13.4
14.1
24
19
NF3AD
NOMESCO Finland
Femur CT
55.6
13.9
16
*
L02BA01
ATC
tamoxifen; oral
55.6
13.9
16
*
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
5.4
13.9
28
55
ZX120
NOMESCO Finland
Intravenous
4.0
13.8
41
111
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.7
13.6
33
76
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
13.6
13
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
13.6
13
*
L01BC06
ATC
capecitabine; oral
+∞
13.6
13
*
L01AX03
ATC
temozolomide; systemic
+∞
13.6
13
*
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
145.2
13.5
14
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
145.2
13.5
14
*
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
19.2
13.5
20
11
N03AF02
ATC
oxcarbazepine; oral
5.6
13.4
26
49
A41.9
ICD-10 Finland
Sepsis, unspecified
5.8
13.2
25
46
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
9.9
13.2
26
28
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.9
13.2
26
28
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
52.0
12.9
15
*
9102
FHL
Trepanation or removal of the local bone process
33.3
12.7
16
5
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.5
12.6
21
34
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
12.6
12
*
1707A
ICD-9 Finland
Malignant neoplasm of bone and articular cartilage, Long bones of lower limb[ALARAAJAN PITKIEN LUIDEN SYÖPÄ,OSTEOSARCOMA]
+∞
12.6
12
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
12.6
12
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
12.2
12.5
22
19
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
12.4
151
870
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.0
12.3
36
96
R4120
NOMESCO Finland
Occupational therapy
4.0
12.3
36
96
Z31.5
ICD-10 Finland
Genetic counselling
5.3
12.1
25
50
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.2
12.0
33
84
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.9
11.9
37
103
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
9.4
11.9
24
27
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
5.4
11.9
24
47
TPX15
NOMESCO Finland
Removal of vascular injection port
67.2
11.7
13
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
11.5
11
*
C40.11
ICD-10 Finland
Osteosarcoma of the short bones of the upper extremity
+∞
11.5
11
*
A04AD12
ATC
aprepitant; systemic
+∞
11.5
11
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
11.5
11
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
11.4
57
215
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
36.3
11.3
14
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
17.7
11.3
17
10
J04AB02
ATC
rifampicin; systemic
26.0
11.2
15
6
NFB60
NOMESCO Finland
Demanding prosthetic replacement of hip
18.5
10.8
16
9
D70.82
ICD-10 Finland
Drug-induced neutropenia
29.0
10.8
14
5
J01FF01
ATC
clindamycin; systemic
2.3
10.8
103
532
HA1AA
NOMESCO Finland
X-ray mammography
8.1
10.6
23
30
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
10.5
10
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
10.5
10
*
C40.93
ICD-10 Finland
Malignant tumor in unspecified locations in the bones and articular cartilage of the extremities
+∞
10.5
10
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
10.5
10
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
10.5
10
*
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
+∞
10.5
10
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
10.5
10
*
9180/3-C40.0
ICD-O-3
Osteosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
10.5
10
*
C40.0
ICD-10 Finland
Malignant neoplasm: Scapula and long bones of upper limb
+∞
10.5
10
*
A79
ICPC
Malignancy NOS
+∞
10.5
10
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
10.5
10
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.7
10.4
34
98
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
9.2
10.4
21
24
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.4
10.2
39
125
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.5
10.2
37
115
ZXE00
NOMESCO Finland
One hour or less
2.1
10.1
146
885
L02BG04
ATC
letrozole; oral
12.7
10.0
17
14
ZXA00
NOMESCO Finland
Right side
2.2
9.9
108
587
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.3
9.9
26
64
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
56.5
9.7
11
*
2392A
ICD-9 Finland
Neoplasm of unspecified nature, Bone, soft tissue and skin
56.5
9.7
11
*
N02AX02
ATC
tramadol; systemic, rectal
2.0
9.6
161
1025
NB1DG
NOMESCO Finland
Shoulder and humerus very extensive MRI examination with high intensity magnet
18.1
9.5
14
8
D16.1
ICD-10 Finland
Benign neoplasm: Short bones of upper limb
102.6
9.5
10
*
S18
ICPC
Laceration/cut
2.0
9.4
165
1065
159
Kela drug reimbursment
Pazopanib
+∞
9.4
9
*
NFA20
NOMESCO Finland
Exploration of hip joint or femur
+∞
9.4
9
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
9220/3-C40.0
ICD-O-3
Chondrosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
9.4
9
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.2
9.2
25
63
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.9
9.2
47
179
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
4.3
9.1
24
59
WZC30
NOMESCO Finland
Teaching
2.7
9.1
54
223
HAB40
NOMESCO Finland
Wedge excision of mammary gland
37.7
9.1
11
*
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
37.7
9.1
11
*
NF1AA
NOMESCO Finland
Hip X-ray examination
3.0
9.0
41
146
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.2
9.0
37
124
D70.89
ICD-10 Finland
Neutropenic splenomegaly
24.7
9.0
12
5
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
8.9
74
357
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
7.5
8.9
20
28
B01AB04
ATC
dalteparin; parenteral
4.1
8.7
24
61
R4190
NOMESCO Finland
Nutritional therapy
4.6
8.7
21
48
R50.9
ICD-10 Finland
Fever, unspecified
2.5
8.6
62
280
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
6.7
8.6
21
33
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
92.1
8.4
9
*
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
92.1
8.4
9
*
N02BE01
ATC
paracetamol; systemic, rectal
2.5
8.4
319
2666
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
8.4
83
430
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
8.4
8
*
17041
ICD-8 Finland
Malignant neoplasm of bone, Long bones of upper limb and scapula
+∞
8.4
8
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
8.4
8
*
GDB10
NOMESCO Finland
Wedge resection of lung
+∞
8.4
8
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
8.4
8
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.4
8
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
8.4
8
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.4
8
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
8.4
8
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
8.4
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.4
8
*
C40.12
ICD-10 Finland
Chondrosarcoma of the short bones of the upper extremity
+∞
8.4
8
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
8.4
8
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
8.4
8
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
8.4
8
*
Z3231
NOMESCO Finland
Registered nurse
2.0
8.4
108
621
ZXD05
NOMESCO Finland
Urgent procedure
2.0
8.3
117
693
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
8.2
98
547
M05BX04
ATC
denosumab; parenteral
4.0
8.1
23
60
J01MA12
ATC
levofloxacin; systemic
2.2
7.9
72
360
ZZR00
NOMESCO Finland
Flap of skin
46.0
7.7
9
*
NF3BA
NOMESCO Finland
Femur extensive X-ray examination
46.0
7.7
9
*
N02BF02
ATC
pregabalin; oral
3.5
7.7
27
82
NG1AD
NOMESCO Finland
Knee CT examination
6.4
7.6
19
31
A06AH03
ATC
naloxegol; oral
25.6
7.6
10
*
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
7.5
80
426
NFQ48
NOMESCO Finland
Revision of exarticulation or amputation stump of hip or femur
81.7
7.4
8
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
81.7
7.4
8
*
M05BA02
ATC
clodronic acid; systemic
81.7
7.4
8
*
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
7.1
7.4
17
25
NF3BD
NOMESCO Finland
Extensive femur CT
+∞
7.3
7
*
C40.92
ICD-10 Finland
Chondrosarcoma in unspecified locations in the bones and articular cartilage of the extremities
+∞
7.3
7
*
C40.23
ICD-10 Finland
Ewing's sarcoma in the long bones of the lower extremity
+∞
7.3
7
*
C40.9
ICD-10 Finland
Malignant neoplasm: Bone and articular cartilage of limb, unspecified
+∞
7.3
7
*
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
7.3
7
*
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
7.3
7
*
C40.81
ICD-10 Finland
Overall osteosarcoma of the extremities' bones and articular cartilage
+∞
7.3
7
*
Z89.6
ICD-10 Finland
Acquired absence of leg above knee
+∞
7.3
7
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
C40.31
ICD-10 Finland
Osteosarcoma of the short bones of the lower extremity
+∞
7.3
7
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
7.3
7
*
116
Kela drug reimbursment
Prostate cancer
+∞
7.3
7
*
WW409
NOMESCO Finland
Other aferesis
+∞
7.3
7
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
30.7
7.2
9
*
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
30.7
7.2
9
*
XW000
NOMESCO Finland
Bone marrow biopsy
5.7
7.0
19
35
L28
ICPC
Limited function/disability (L)
2.1
6.9
72
379
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
14.1
6.9
11
8
Z3226
NOMESCO Finland
Physiotherapist
2.1
6.9
73
387
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
11.2
6.8
12
11
WX002
NOMESCO Finland
Sedation and analgesia
2.1
6.8
73
389
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
6.6
63
320
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.1
6.6
28
96
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
10.3
6.6
12
12
C03CA01
ATC
furosemide; systemic
1.9
6.6
110
684
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.9
6.5
17
30
C90.0
ICD-10 Finland
Multiple myeloma
71.0
6.4
7
*
D16.0
ICD-10 Finland
Benign neoplasm: Scapula and long bones of upper limb
71.0
6.4
7
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
6.4
42
181
JN6AD
NOMESCO Finland
CT of torso and neck
14.6
6.4
10
7
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
8.4
6.4
13
16
NGR40
NOMESCO Finland
Extensive excision of tumor of knee or lower leg with repair
+∞
6.3
6
*
C40.39
ICD-10 Finland
Malignant tumor of the lower extremity of the short bones or other unspecified histology
+∞
6.3
6
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
6.3
6
*
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
6.3
6
*
NK6AT
NOMESCO Finland
Bone biopsy with ultrasound guidance
+∞
6.3
6
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
+∞
6.3
6
*
C40.1
ICD-10 Finland
Malignant neoplasm: Short bones of upper limb
+∞
6.3
6
*
C49.28
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip Ewing's sarcoma
+∞
6.3
6
*
343
Kela drug reimbursment
Pazopanib
+∞
6.3
6
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
6.3
6
*
C41.42
ICD-10 Finland
Chondrosarcoma of the pelvic bones, sacrum and coccyx
+∞
6.3
6
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
27.2
6.3
8
*
ZZR30
NOMESCO Finland
Flap of muscle
27.2
6.3
8
*
AA1AD
NOMESCO Finland
CT of head and brain
1.9
6.1
97
591
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
12.8
6.1
10
8
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
5.7
6.1
16
29
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
6.2
6.1
15
25

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
57
64
10.36
47.61
1.7
1.3
—
—
—
0
0
105
337
3.97
28.78
13.1
3.7
0.79
0.83
mmol/l
2.11
96
317
166
743
3.26
26.77
4.0
2.0
—
—
—
0
0
172
805
3.14
25.40
2.9
1.6
—
—
—
0
0
208
1133
2.94
22.62
14.7
5.8
1.21
1.21
mmol/l
0.08
191
1023
132
575
3.03
21.46
4.5
2.0
—
—
—
0
0
219
1252
2.87
21.31
16.4
6.2
1.21
1.21
mmol/l
0.69
186
1098
218
1259
2.81
20.54
14.2
3.8
9.20
11.88
umol/l
8.03
209
1188
161
819
2.72
19.13
7.9
2.0
2.35
2.35
mmol/l
0.07
148
685
138
661
2.75
18.31
6.9
3.7
—
—
—
0
0
200
1160
2.60
17.84
4.1
2.3
—
—
—
0
0
189
1071
2.58
17.65
8.9
3.9
34.19
36.07
g/l
4.48
176
992
79
284
3.27
17.51
8.2
8.7
0.78
1.44
mmol/l
0.77
66
230
61
189
3.67
17.03
1.4
1.1
—
—
—
0
0
16
0
+∞
16.79
31.9
0.0
0.37
—
umol/l
—
16
0
236
1509
2.59
16.73
21.4
6.4
3.99
4.20
e9/l
0.65
216
1305
84
326
3.05
16.27
12.2
5.8
1.09
1.08
mmol/l
0.06
76
298
126
618
2.58
15.52
16.7
5.1
—
—
—
0
0
140
729
2.49
15.12
8.1
3.0
7.40
7.40
ph
0.05
30
104
78
312
2.91
14.18
18.3
5.8
104.95
104.43
mmol/l
0.39
78
312
87
371
2.76
14.02
2.4
1.9
—
—
—
0
0
194
1203
2.30
13.73
14.4
13.8
1.10
1.30
inr
3.95
48
345
43
124
3.80
13.23
4.1
1.4
64.55
2.66
ug/l
0.55
32
95
42
120
3.82
13.09
11.1
8.9
24.03
24.85
mmol/l
0.93
42
115
276
2024
2.48
12.72
14.8
5.2
88.22
77.12
u/l
1.87
266
1857
98
469
2.49
12.36
6.1
2.0
2.48
2.42
mmol/l
1.94
89
391
230
1579
2.23
12.12
10.3
4.4
6.65
6.72
mmol/l
0.16
221
1463
210
1396
2.18
11.93
9.3
5.4
1.67
1.87
e9/l
3.34
192
1238
204
1363
2.12
11.17
9.4
5.3
0.03
0.04
e9/l
2.50
184
1180
203
1356
2.12
11.10
9.5
5.3
0.58
0.58
e9/l
0.03
184
1172
30
76
4.21
10.98
20.3
7.6
1.25
1.51
mg/l
1.22
30
68
47
164
3.14
10.74
2.9
4.3
0.66
0.28
%
1.23
29
39
50
181
3.04
10.74
3.0
4.2
1.13
0.76
%
0.92
32
49
56
218
2.85
10.56
16.2
7.4
—
—
—
0
0
55
214
2.85
10.38
20.9
6.1
1.20
1.44
mmol/l
0.73
55
207
38
122
3.36
9.93
8.6
12.8
—
—
—
0
0
205
1413
2.02
9.86
11.2
5.6
0.19
0.20
e9/l
0.25
188
1232
186
1253
1.99
9.40
12.0
5.8
—
—
—
0
0
45
171
2.86
8.84
3.0
4.3
0.07
0.08
%
0.04
27
37
20
44
4.75
8.70
7.3
1.3
—
—
—
0
0
190
1313
1.93
8.68
9.7
5.5
25.41
28.35
%
3.13
184
1230
180
1224
1.93
8.61
9.8
5.5
0.63
0.68
%
0.69
174
1133
186
1281
1.92
8.54
10.2
5.7
8.95
8.55
%
1.00
180
1194
185
1273
1.92
8.51
9.7
5.4
2.70
3.00
%
0.91
179
1181
24
63
4.01
8.38
7.8
1.4
51.42
31.03
mg/l
0.27
19
54
24
63
4.01
8.38
7.8
1.4
42.69
42.85
mg/l
0.00
19
53
187
1298
1.90
8.31
9.5
5.3
58.53
56.97
%
1.01
181
1215
18
40
4.68
7.73
1.6
1.6
—
—
—
0
0
121
751
1.91
7.39
3.5
2.9
0.22
0.35
e6/l
1.25
96
556
64
317
2.23
7.19
2.3
1.7
—
—
—
0
0
14
17
8.51
6.89
2.0
4.8
—
—
—
0
0
40
165
2.60
6.71
3.0
4.3
0.00
0.03
%
0.49
21
31
45
199
2.44
6.53
2.7
2.6
0.20
0.21
g/l
0.50
45
180
12
13
9.50
6.33
4.9
2.5
39.18
43.82
%
0.31
12
13
171
1225
1.74
6.29
17.6
7.4
0.00
0.00
e9/l
0.42
148
988
124
821
1.77
5.94
3.9
3.0
44.72
137.47
e6/l
0.59
99
619
113
730
1.79
5.87
3.6
2.8
—
—
—
0
0
57
295
2.10
5.70
4.4
2.5
4.65
7.82
umol/l
1.81
51
260
61
326
2.05
5.60
3.1
2.4
21.30
24.40
%
0.93
55
292
16
42
3.94
5.60
3.3
3.6
60.06
57.98
%
0.23
16
42
11
13
8.68
5.59
4.0
1.2
590.09
787.08
e6/l
0.48
11
13
88
534
1.85
5.57
4.0
2.7
547.28
558.73
mosm/kgh2o
0.22
80
443
39
174
2.39
5.56
1.5
1.4
—
—
—
0
0
116
766
1.75
5.54
3.4
2.9
—
—
—
0
0
90
554
1.83
5.44
3.5
2.4
5.99
4.97
e6/l
0.33
85
490
105
689
1.73
5.07
3.3
2.3
3653.25
8304.78
umol/l
0.61
95
615
34
150
2.40
4.97
5.2
1.4
—
—
—
0
0
15
42
3.68
4.81
2.9
3.1
4.65
4.55
e9/l
0.05
15
42
8
7
11.65
4.80
1.1
1.0
—
—
—
0
0
134
951
1.65
4.78
4.9
3.5
44.56
92.79
e6/l
1.43
105
665
8
9
9.05
4.30
2.4
1.3
3.29
3.30
mg/l
—
8
9
16
52
3.17
4.13
3.1
4.2
—
—
—
0
0
42
221
2.02
4.02
4.5
3.1
—
—
—
0
0
12
28
4.39
3.85
1.7
1.5
61.50
64.39
%
—
6
23
39
204
2.02
3.80
6.6
2.4
74.12
65.74
e9/l
0.93
34
163
7
8
8.89
3.79
1.1
1.0
—
—
—
0
0
35
176
2.09
3.78
4.5
7.7
—
—
—
0
0
23
98
2.44
3.65
6.1
2.2
20.78
20.92
s
0.07
23
88
52
307
1.81
3.55
1.8
1.5
—
—
—
0
0
11
26
4.33
3.53
1.4
1.1
—
—
—
0
0
9
17
5.40
3.53
2.0
1.1
—
—
—
0
0
226
1895
1.50
3.48
5.0
4.0
—
—
—
0
0
27
127
2.22
3.45
26.5
2.5
0.72
0.66
%
0.55
27
127
242
2066
1.51
3.35
4.9
4.0
15.54
10.81
mm/h
3.65
229
1891
320
2916
1.77
3.32
33.9
13.9
139.09
139.77
mmol/l
3.69
312
2834
320
2919
1.77
3.27
34.2
14.0
3.93
3.98
mmol/l
2.68
311
2834
67
436
1.66
3.24
3.2
2.7
2.50
2.61
e6/l
0.05
35
226
14
49
2.93
3.22
1.9
1.2
—
—
—
0
0
27
131
2.15
3.21
26.5
2.6
1.39
1.24
%
0.42
27
131
36
195
1.94
3.20
8.3
5.0
7.43
7.41
ph
—
5
19
11
30
3.75
3.11
1.4
1.8
—
—
—
0
0
227
1930
1.46
3.08
3.9
3.6
—
—
—
0
0
6
8
7.60
3.06
1.0
1.1
—
—
—
0
0
6
8
7.60
3.06
1.2
2.4
0.16
0.19
e9/l
—
6
8
111
824
1.50
3.03
3.6
2.3
53.10
61.22
u/l
0.66
103
767
52
323
1.71
2.99
1.5
1.4
—
—
—
0
0
137
1064
1.46
2.97
4.4
3.6
24.94
46.38
ng/l
1.89
107
710
12
37
3.32
2.96
3.0
1.4
—
—
—
0
0
46
277
1.76
2.95
25.2
3.6
1.65
2.07
mmol/l
0.39
40
223
8
17
4.79
2.93
1.3
1.1
—
—
—
0
0
7
13
5.47
2.88
1.3
1.1
—
—
—
0
0
6
9
6.75
2.88
2.8
1.4
29.49
13.43
ug/l
—
6
9
6
9
6.75
2.88
1.0
1.1
—
—
—
0
0
18
77
2.41
2.86
1.8
1.8
14.69
7.25
u/l
0.86
11
68
311
2843
1.62
2.81
28.1
11.7
28.18
22.46
mg/l
1.90
278
2116
91
659
1.51
2.78
2.3
2.3
3.27
2.97
mg/l
0.38
80
564
7
14
5.07
2.74
2.0
2.0
—
—
—
0
0
40
237
1.77
2.71
2.5
2.1
41.37
30.04
u/l
0.87
35
190
9
24
3.82
2.69
1.2
1.1
31.13
24.13
g/l
—
9
19
11
35
3.21
2.66
1.8
1.6
—
—
—
0
0
15
61
2.52
2.65
1.7
1.7
15122.40
15625.82
e6/l
—
10
44
13
49
2.71
2.65
2.5
2.7
15.59
16.70
%
—
8
28
164
1338
1.41
2.65
4.8
3.5
0.00
0.00
estimate
0.50
39
237
14
55
2.61
2.64
40.4
2.8
—
—
—
0
0
140
1114
1.42
2.60
2.4
2.4
78.97
76.95
nmol/l
0.34
126
992
8
20
4.07
2.58
2.3
1.9
—
—
—
0
0
8
20
4.07
2.58
1.3
1.0
—
—
—
0
0
164
1343
1.40
2.57
6.1
4.8
0.00
0.00
estimate
-0.00
38
219
277
2490
1.46
2.50
32.4
13.7
14.85
14.58
%
0.39
277
2446
15
63
2.44
2.49
3.2
3.0
—
—
—
0
0
7
16
4.44
2.48
1.0
1.2
—
—
—
0
0
165
1359
1.39
2.47
4.9
3.4
0.00
0.00
estimate
-0.00
38
220
13
52
2.56
2.38
3.8
4.1
2.78
3.01
mmol/l
—
6
32
5
8
6.32
2.38
1.4
1.0
—
—
—
0
0
136
1098
1.38
2.26
3.9
3.3
6.08
5.74
ph
—
6
86
21
108
2.00
2.20
10.3
5.2
—
—
—
0
0
15
68
2.26
2.14
3.6
3.9
7.40
7.41
ph
0.15
15
58
92
701
1.42
2.13
6.0
3.6
0.00
0.00
estimate
-0.00
37
216
12
49
2.50
2.12
2.1
1.9
5.36
5.08
mmol/24h
0.12
12
43
58
405
1.51
2.09
1.7
1.6
—
—
—
0
0
6
15
4.05
2.04
1.0
1.5
—
—
—
0
0
32
194
1.71
2.04
3.5
2.4
3.32
4.09
e9/l
1.62
27
157
82
617
1.42
2.03
4.2
3.5
—
—
—
0
0
102
798
1.39
2.02
4.8
3.1
1883.21
1269.52
ng/l
0.43
89
673
7
21
3.38
1.97
79.0
2.0
9.96
12.23
%
—
7
21
5
11
4.59
1.94
1.4
1.0
1774.20
1713.27
miu/ml
—
5
11
8
27
3.01
1.94
2.0
3.0
—
—
—
0
0
91
706
1.38
1.88
1.6
1.4
—
—
—
0
0
5
12
4.21
1.83
2.8
2.3
—
—
—
0
0
17
308
0.53
1.81
1.6
1.7
—
—
—
0
0
79
605
1.39
1.76
3.9
1.7
1.62
1.13
mg/l
0.78
61
443
6
18
3.37
1.75
1.2
1.0
—
—
—
0
0
7
24
2.95
1.73
2.3
1.3
30.43
32.79
pg
—
7
24
10
40
2.54
1.68
4.9
3.8
—
—
—
0
0
34
222
1.59
1.67
6.2
3.0
—
—
—
0
0
15
76
2.02
1.67
1.4
1.1
—
—
—
0
0
7
25
2.83
1.65
1.9
1.2
—
—
—
0
0
24
144
1.71
1.62
10.7
5.6
—
—
—
0
0
35
232
1.56
1.62
8.5
3.4
—
—
—
0
0
11
50
2.24
1.58
52.2
1.9
58.49
66.13
%
0.52
11
50
13
64
2.07
1.56
1.7
1.3
221.38
320.68
ug/g
—
8
33
8
33
2.46
1.54
2.4
1.6
3.15
117.03
u/ml
—
8
33
23
140
1.69
1.49
3.3
2.6
0.69
0.24
e6/l
0.35
23
134
11
52
2.15
1.46
2.7
2.6
—
—
—
0
0
10
196
0.50
1.39
1.3
1.4
—
—
—
0
0
261
2789
0.78
1.36
4.4
4.3
4.55
4.61
mmol/l
0.36
238
2595
18
293
0.59
1.35
1.3
1.3
—
—
—
0
0
9
42
2.17
1.34
1.1
1.1
—
—
—
0
0
9
42
2.17
1.34
1.1
1.1
—
—
—
0
0
30
202
1.53
1.32
2.3
2.1
11.86
15.01
nmol/l
0.73
25
191
6
24
2.52
1.31
1.0
1.1
—
—
—
0
0
5
18
2.80
1.29
1.6
1.1
166.80
158.37
mmol/24h
—
5
18
5
115
0.43
1.27
1.2
1.1
—
—
—
0
0
6
25
2.42
1.25
1.5
3.0
—
—
—
0
0
59
748
0.75
1.24
1.7
1.7
1.22
1.37
mmol/l
0.88
54
629
5
19
2.65
1.22
1.8
1.2
—
—
—
0
0
70
558
1.31
1.22
3.1
3.9
51.48
417.97
ng/l
2.09
60
441
36
257
1.44
1.21
1.4
1.3
—
—
—
0
0
6
26
2.33
1.19
2.7
1.6
—
—
—
0
0
23
150
1.57
1.17
1.2
1.2
—
—
—
0
0
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
34
466
0.70
1.16
1.2
1.3
5.77
9.78
u/ml
0.38
14
191
100
840
1.26
1.16
3.3
2.1
686.80
297.61
u/l
0.50
93
786
260
2763
0.80
1.16
4.3
4.3
1.43
1.45
mmol/l
0.27
236
2557
5
20
2.52
1.15
1.2
1.3
—
—
—
0
0
5
21
2.40
1.09
1.4
1.0
—
—
—
0
0
5
22
2.29
1.03
2.4
2.6
—
—
—
0
0
270
2843
0.81
0.99
4.5
4.8
2.70
2.74
mmol/l
0.25
244
2632
316
3032
1.31
0.99
19.0
8.3
27.81
26.08
u/l
0.67
306
2915
90
766
1.23
0.93
4.8
3.0
—
—
—
0
0
5
102
0.48
0.91
4.2
1.6
—
—
—
0
0
108
942
1.21
0.88
4.3
3.6
1.81
1.88
ug/l
0.12
98
830
38
486
0.76
0.86
1.3
1.3
57.59
37.82
iu/ml
0.23
17
154
228
2128
1.19
0.86
4.4
3.7
14.60
14.80
pmol/l
0.57
210
1929
252
2657
0.83
0.84
4.0
3.9
1.28
1.27
mmol/l
0.04
227
2447
244
2578
0.84
0.83
5.8
5.7
39.81
39.97
mmol/mol
0.09
222
2408
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
13
82
1.61
0.79
4.0
3.7
—
—
—
0
0
87
999
0.83
0.78
2.8
2.8
—
—
—
0
0
0
28
0.00
0.76
0.0
1.2
—
178.60
—
0
28
9
53
1.72
0.76
1.1
1.2
—
—
—
0
0
200
1860
1.17
0.74
3.9
3.0
53.49
42.27
u/l
1.73
193
1741
311
3005
1.23
0.71
23.9
10.9
—
—
—
0
0
15
101
1.51
0.71
1.7
1.3
—
—
—
0
0
7
41
1.72
0.70
3.6
2.3
—
—
—
0
0
7
42
1.68
0.68
3.6
2.3
4.01
4.06
mmol/l
—
7
42
7
42
1.68
0.68
3.6
2.3
105.14
105.50
mmol/l
—
7
42
5
28
1.80
0.66
1.4
1.6
91.26
90.68
%
—
5
28
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
5
30
1.68
0.61
1.4
1.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.5
—
6.73
—
0
20
0
21
0.00
0.60
0.0
1.0
—
241.06
—
0
16
130
1189
1.14
0.58
3.4
2.6
181.28
105.80
ug/l
1.99
123
1094
84
746
1.16
0.56
5.4
3.8
—
—
—
0
0
74
651
1.17
0.55
1.7
1.5
19.11
20.98
nmol/l
0.53
65
565
58
502
1.18
0.53
1.7
1.9
—
—
—
0
0
8
121
0.65
0.46
1.0
1.1
—
—
—
0
0
265
2735
0.89
0.44
4.5
4.3
5.94
5.93
mmol/l
0.05
237
2487
11
78
1.42
0.43
1.3
1.2
—
2.94
—
0
14
22
271
0.80
0.42
1.9
1.7
—
—
—
0
0
8
58
1.39
0.42
1.0
1.2
—
—
—
0
0
5
33
1.52
0.41
1.4
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
21.33
—
0
6
25
302
0.82
0.40
1.3
1.5
—
—
—
0
0
267
2588
1.12
0.40
5.0
4.5
1.96
1.89
mu/l
0.32
245
2364
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
9
66
1.37
0.38
2.7
2.1
127.67
129.58
g/l
—
9
46
14
180
0.77
0.37
1.2
1.4
—
—
—
0
0
9
69
1.31
0.37
1.0
1.3
76.78
1688.57
e6/l
—
9
58
9
69
1.31
0.37
1.0
1.2
1.89
3.65
e6/l
—
9
57
6
43
1.40
0.35
1.7
3.3
0.78
0.78
nmol/l
—
6
31
6
44
1.37
0.34
7.8
1.1
18.63
16.33
u/l
—
6
38
18
145
1.25
0.34
3.5
3.3
—
—
—
0
0
10
74
1.36
0.32
4.2
1.7
—
—
—
0
0
33
376
0.87
0.30
2.1
2.4
133.89
100.76
ug/g
0.29
27
291
13
104
1.26
0.27
1.4
1.6
—
—
—
0
0
11
138
0.79
0.26
2.3
1.4
—
—
—
0
0
16
191
0.83
0.25
1.0
1.2
—
—
—
0
0
12
146
0.82
0.22
2.8
1.4
—
—
—
0
0
68
635
1.09
0.22
5.3
3.6
1.02
1.02
kg/l
—
10
90
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.8
—
134.20
—
0
10
12
145
0.82
0.21
2.2
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
98
931
1.07
0.21
3.5
3.1
7.46
7.78
mmol/l
0.30
85
797
5
43
1.16
0.21
2.2
1.3
95.00
60.06
pmol/l
—
5
43
6
48
1.25
0.20
6.5
3.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
1.56
—
0
14
12
144
0.83
0.20
2.2
1.4
—
—
—
0
0
12
144
0.83
0.20
2.2
1.4
—
—
—
0
0
15
175
0.85
0.19
5.4
2.6
—
—
—
0
0
326
3226
1.10
0.18
44.2
16.9
38.38
40.69
%
10.09
304
2997
326
3227
1.09
0.17
41.7
16.9
90.72
90.53
fl
0.29
321
3171
5
67
0.74
0.17
1.0
1.2
—
—
—
0
0
63
594
1.07
0.17
2.4
1.3
2.35
2.42
g/l
0.06
48
366
326
3228
1.09
0.17
41.9
16.9
4.32
4.57
e12/l
12.69
320
3128
326
3228
1.09
0.17
41.7
16.8
30.22
30.23
pg
0.03
321
3172
326
3229
1.09
0.16
41.9
16.9
6.78
6.66
e9/l
0.40
320
3133
8
72
1.11
0.16
1.0
1.4
0.57
0.85
nmol/l
—
8
60
15
130
1.16
0.16
1.5
1.7
—
—
—
0
0
326
3231
1.08
0.15
42.1
17.0
128.56
137.46
g/l
17.82
321
3172
7
88
0.79
0.14
1.0
1.7
228.43
302.54
mu/l
—
7
79
11
93
1.19
0.14
1.1
1.2
—
—
—
0
0
8
97
0.82
0.14
4.6
7.8
—
—
—
0
0
11
94
1.18
0.13
1.4
1.5
—
—
—
0
0
41
385
1.07
0.12
1.2
1.4
440.00
502.59
titre
—
6
85
60
574
1.05
0.11
2.3
1.7
442.52
436.83
pmol/l
0.05
50
479
325
3227
1.06
0.10
42.1
16.9
246.49
247.82
e9/l
0.14
319
3137
55
526
1.05
0.10
2.5
2.5
0.78
0.71
ug/l
0.21
38
331
52
497
1.05
0.10
2.2
1.7
1375.65
1190.57
nmol/l
0.81
40
378
113
1102
1.04
0.09
1.9
1.9
95.64
94.65
pmol/l
0.07
62
563
10
88
1.14
0.08
1.0
1.1
—
—
—
0
0
7
64
1.10
0.08
3.1
1.9
—
—
—
0
0
7
66
1.06
0.08
4.0
1.5
—
—
—
0
0
86
881
0.97
0.07
4.0
3.7
6.61
6.97
mg/mmol
0.04
60
552
8
95
0.84
0.06
1.4
1.4
1.15
1.16
g/l
—
8
90
85
831
1.03
0.06
3.6
3.2
1899.70
126.50
mg/l
1.01
61
536
10
110
0.91
0.05
2.4
1.4
—
—
—
0
0
16
150
1.07
0.04
1.9
2.3
—
—
—
0
0
23
239
0.96
0.03
1.2
1.2
—
—
—
0
0
36
358
1.01
0.00
1.1
1.2
—
—
—
0
0
67
672
1.00
0.00
1.2
1.4
1.03
2.10
u/ml
1.26
18
187
14
144
0.97
0.00
1.1
1.1
—
6.20
—
0
5
5
49
1.02
0.00
1.0
1.2
—
—
—
0
0
26
260
1.00
-0.00
1.3
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
8.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
7.3
—
—
—
0
0
7
74
0.94
-0.00
1.4
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.4
—
—
—
0
0
9
94
0.96
-0.00
1.3
1.4
0.19
0.22
g/l
—
9
89
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
8.2
—
25.44
—
0
9
0
7
0.00
-0.00
0.0
7.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
2.03
—
0
5

Mortality – FinRegistry

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

Index endpoint: C3_BONE_CARTILAGE_LIMBS_WIDE – Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).